期刊文献+

胰腺癌K-ras基因12密码子突变方式的研究 被引量:1

A study on the mutation style of K-ras condon 12 in pancreatic adenocarcinoma
下载PDF
导出
摘要 目的 阐明中国胰腺癌患者K -ras基因 12密码子突变方式。方法 采用 3′碱基特异性引物PCR技术分析 30例已证明存在突变的胰腺癌DNA标本。结果 检测到 4种突变方式即GAT、GTT、CGT和GCT ,比例分别为 5 2 .9%、32 .4%、8.8%和 5 .9%。结论 中国胰腺癌K -ras基因 12密码子存在 4种突变方式 。 Objective To investigate the mutation style of K-ras codon 12 in Chinese patients with pancreatic adenocarcinoma. Methods 30 DNA specimens of pancreatic adenocarcinoma which had been proved to have the mutation were analysed by 3′base special prime PCR method. Results Four styles were detected,i.e. GAT,GTT,CGT and GCT,of which the ratios were 52.9%,32.4%,8.8% and 5.9% respectively. Conclusion There are 4 styles of mutation of K-ras codon 12 in pancreatic adenocarcinomas in China, which might be varied with different geographical zones.
出处 《徐州医学院学报》 CAS 2000年第6期433-435,共3页 Acta Academiae Medicinae Xuzhou
基金 江苏省教委自然科学基金!资助课题 (94116 )
关键词 胰腺癌 K-ras基因12密码子 基因突变 PCR pancreatic neoplasms ras genes mutation polymerase chain reaction
  • 相关文献

参考文献5

共引文献6

同被引文献24

  • 1Kleeff J,Friess H,Berberat P O,et al. Pancreatic cancer-new aspectys of molecular biology research[J].Swiss Surg,2000,6(5):231-234.
  • 2Greenlee R T,Harmon M B,Murray T,et al. Cancer statistics,2001[J].CA Cancer J Clin,2001,51(1):15-36.
  • 3Fearon E R,Vogelstein B,Kinzler K W. The genetic basis of human cancer[M].New York:McGraw-Hill,1998.229-236.
  • 4Nake T,Kobayashi M,Ashida K,et al. Aberrant p16 INK4 expression related to clinical stage and prognosis in patients with pancreatic cancer[J].Int J Oncol,1998,12(5):1111-1116.
  • 5Serrano M,Hannon G J,Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4[J].Nature,1993,366(6456):704-707.
  • 6Caldas C,Hahn S A,daCosta L,et al. Frequent somaticmutations and homozygous deletions of the MTSI gene in pancreatic adenocarcinoma[J].Nature Genet,1994,8(1):27-32.
  • 7Huang L,Goodrow T L,Zhang S Y,et al. Deletion and mutation analysis of the p16/MTS1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell line than in primary ductal adenocarcinomas[J].Cancer Res,1996,56(5):1137-1141.
  • 8Bartsh D,Shevlin D W,Tung W S,et al. Frequent mutations of CDKN2 in primary pancreatic adenocarcinoma Genes[J].Chromosomes & Cancer,1995,14(3):189-195.
  • 9Muscarella P,Melvin W S,Fisher W E,et al. Genetic alteration in gastrinimas and nonfunctioning pancreatic neuroendocrine tumor,an analysis of p16/MTS1 tumor suppressor gene inactivation[J].Cancer Res,1998,58(2):237.
  • 10Serrano M,Hannon G J,Beach D. A new regulation motif in cellcycle control causing specific inhibition of cyclin D/CDK4[J].Nature,1993,366(6456):704-707.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部